← FDA DRUG APPROVALS

FDA ANDA · ANDA087194

SOMOPHYLLIN-CRT

Sponsor: GRAHAM DM

APPLICATION
ANDA087194
TYPE
ANDA
ORIGINAL APPROVAL
1981-09-17
LATEST ACTION
1997-03-13
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

SOMOPHYLLIN-CRTDiscontinued
THEOPHYLLINE 100MG · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

1997-03-13Labeling · Supplement 34AP
1997-03-13Labeling · Supplement 26AP
1997-03-13Labeling · Supplement 18AP
1990-11-20Labeling · Supplement 21AP
1981-09-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →